title: Impact of ileocecal resection and concomitant antibiotics on the microbiome of the murine jejunum and colon.
abstract: Ileocecal resection (ICR) is a commonly required surgical intervention in unmanageable Crohn's disease and necrotizing enterocolitis. However, the impact of ICR, and the concomitant doses of antibiotic routinely given with ICR, on the intestinal commensal microbiota has not been determined. In this study, wild-type C57BL6 mice were subjected to ICR and concomitant single intraperitoneal antibiotic injection. Intestinal lumen contents were collected from jejunum and colon at 7, 14, and 28 days after resection and compared to non-ICR controls. Samples were analyzed by 16S rRNA gene pyrosequencing and quantitative PCR. The intestinal microbiota was altered by 7 days after ICR and accompanying antibiotic treatment, with decreased diversity in the colon. Phylogenetic diversity (PD) decreased from 11.8 ± 1.8 in non-ICR controls to 5.9 ± 0.5 in 7-day post-ICR samples. There were also minor effects in the jejunum where PD values decreased from 8.3 ± 0.4 to 7.5 ± 1.4. PCoA analysis indicated that bacterial populations 28 days post-ICR differed significantly from non-ICR controls. Moreover, colon and jejunum bacterial populations were remarkably similar 28 days after resection, whereas the initial communities differed markedly. Firmicutes and Bacteroidetes were the predominant phyla in jejunum and colon before ICR; however, Firmicutes became the vastly predominant phylum in jejunum and colon 28 days after ICR. Although the microbiota returned towards a homeostatic state, with re-establishment of Firmicutes as the predominant phylum, we did not detect Bacteroidetes in the colon 28 days after ICR. In the jejunum Bacteroidetes was detected at a 0.01% abundance after this time period. The changes in jejunal and colonic microbiota induced by ICR and concomitant antibiotic injection may therefore be considered as potential regulators of post-surgical adaptive growth or function, and in a setting of active IBD, potential contributors to post-surgical pathophysiology of disease recurrence.
authors.affiliation: Department of Cell Biology and Physiology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
authors.forename: Anthony A
authors.initials: AA
authors.lastname: Devine
authors.forename: Antonio
authors.initials: A
authors.lastname: Gonzalez
authors.forename: K Elizabeth
authors.initials: KE
authors.lastname: Speck
authors.forename: Rob
authors.initials: R
authors.lastname: Knight
authors.forename: Michael
authors.initials: M
authors.lastname: Helmrath
authors.forename: P Kay
authors.initials: PK
authors.lastname: Lund
authors.forename: M Andrea
authors.initials: MA
authors.lastname: Azcarate-Peril
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D041963:Bacteroidetes / Q000235:genetics* / Q000254:growth & development; D003106:Colon / Q000382:microbiology / Q000601:surgery; D003424:Crohn Disease / Q000382:microbiology / Q000601:surgery; D006801:Humans; D007583:Jejunum / Q000382:microbiology / Q000601:surgery; D051379:Mice; D064307:Microbiota / Q000235:genetics*; D010802:Phylogeny; D012336:RNA, Ribosomal, 16S / Q000235:genetics*; D017423:Sequence Analysis, RNA
chemical_list: D000900:Anti-Bacterial Agents; D012336:RNA, Ribosomal, 16S